With confirmation of the cytotoxic effects of IL-13-PE on cultured primary murine HNSCC tumor cells, we next decided to treat Tgfbr1/Pten 2cKO mice with i.p. injections of the recombinant immunotoxin. This evidence concerns the gene IL13 and neoplasm.